Pharmacology & Pharmacy
Vol.4 No.9(2013), Paper ID 40663, 5
pages
DOI:10.4236/pp.2013.49094
Evolution of Biochemical Effects of Byetta® in Type 2 Diabetics with Cardiovascular Risk
Alfonso López Ruiz, María Ángeles Ibáñez Gil, Pedro Pujante Alarcón, Alicia Hernández Torres, Ana Belen Hernández Cascales, María Dolores Hellín Gil
Pharmaceutical Care Research at the University of Granada, Granada, Spain;
Health Center Mariano Yago, Yecla, Murcia, Spain;
Endocrinology and Nutrition Service of the Hospital University Virgen de la Arrixaca, Murcia, Spain
Infectious Internal Medicine of the Hospital University Virgen de la Arrixaca, Murcia, Spain.
Endocrinology and Nutrition Service of the Hospital University Virgen de la Arrixaca, Murcia, Spain;
Endocrinology and Nutrition Service of the Hospital University Virgen de la Arrixaca, Murcia, Spain;
Copyright © 2013 Alfonso López Ruiz, María Ángeles Ibáñez Gil, Pedro Pujante Alarcón, Alicia Hernández Torres, Ana Belen Hernández Cascales, María Dolores Hellín Gil et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
A. López Ruiz, M. Gil, P. Alarcón, A. Torres, A. Cascales and M. Gil, "Evolution of Biochemical Effects of Byetta
® in Type 2 Diabetics with Cardiovascular Risk,"
Pharmacology & Pharmacy, Vol. 4 No. 9, 2013, pp. 679-683. doi:
10.4236/pp.2013.49094.